Hempacco Co., Inc. (HPCO)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -8.81 Million USD | -64.33% |
| 2022 | -5.36 Million USD | -223.18% |
| 2021 | -1.65 Million USD | -27.15% |
| 2020 | -1.3 Million USD | -2360.39% |
| 2019 | -53.04 Thousand USD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 Q2 | -1.63 Million USD | 31.38% |
| 2023 Q1 | -2.37 Million USD | 53.28% |
| 2023 FY | -8.81 Million USD | -64.33% |
| 2023 Q4 | -4.17 Million USD | -97.6% |
| 2023 Q3 | -2.11 Million USD | -29.57% |
| 2022 Q4 | -5.08 Million USD | -387.42% |
| 2022 Q3 | -1.04 Million USD | -1037.66% |
| 2022 Q2 | -91.76 Thousand USD | 89.33% |
| 2022 FY | -5.36 Million USD | -223.18% |
| 2022 Q1 | -860.15 Thousand USD | -19.61% |
| 2021 Q1 | -293.61 Thousand USD | -175.62% |
| 2021 FY | -1.65 Million USD | -27.15% |
| 2021 Q4 | -719.13 Thousand USD | -129.18% |
| 2021 Q3 | -313.78 Thousand USD | 5.71% |
| 2021 Q2 | -332.79 Thousand USD | -13.35% |
| 2020 FY | -1.3 Million USD | -2360.39% |
| 2020 Q4 | 388.24 Thousand USD | 0.0% |
| 2019 FY | -53.04 Thousand USD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | -155.56 Million USD | 94.335% |
| Theratechnologies Inc. | -10.62 Million USD | 17.077% |
| Safety Shot Inc | -12.18 Million USD | 27.674% |
| Cosmos Health Inc. | -21.83 Million USD | 59.634% |
| Cronos Group Inc. | -81.37 Million USD | 89.171% |
| Ironwood Pharmaceuticals, Inc. | 209.03 Million USD | 104.216% |
| Kala Pharmaceuticals, Inc. | -39.15 Million USD | 77.493% |
| Organogenesis Holdings Inc. | 12.52 Million USD | 170.358% |
| Universe Pharmaceuticals INC | -3.52 Million USD | -149.868% |
| ProPhase Labs, Inc. | -21.61 Million USD | 59.227% |
| Sonoma Pharmaceuticals, Inc. | -4.7 Million USD | -87.455% |
| Dynavax Technologies Corporation | -37.02 Million USD | 76.201% |
| Radius Health, Inc. | -3.92 Million USD | -124.517% |
| China SXT Pharmaceuticals, Inc. | -2.51 Million USD | -250.359% |
| Alvotech | -354.86 Million USD | 97.517% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -84.153% |
| Alpha Teknova, Inc. | -35.56 Million USD | 75.221% |
| Intra-Cellular Therapies, Inc. | -159.38 Million USD | 94.471% |
| SCYNEXIS, Inc. | 72.66 Million USD | 112.127% |
| Harrow Health, Inc. | 580 Thousand USD | 1619.359% |
| Biofrontera Inc. | -22.67 Million USD | 61.14% |
| DURECT Corporation | -36.88 Million USD | 76.108% |
| Supernus Pharmaceuticals, Inc. | -5.26 Million USD | -67.248% |
| ANI Pharmaceuticals, Inc. | 46.97 Million USD | 118.761% |
| OptiNose, Inc. | -22.74 Million USD | 61.261% |
| RedHill Biopharma Ltd. | 12.63 Million USD | 169.762% |
| Aquestive Therapeutics, Inc. | -15.1 Million USD | 41.648% |
| Cumberland Pharmaceuticals Inc. | -6.21 Million USD | -41.886% |
| SIGA Technologies, Inc. | 83.62 Million USD | 110.538% |
| Lifecore Biomedical, Inc. | 9.33 Million USD | 194.441% |
| Shineco, Inc. | -17.06 Million USD | 48.363% |
| Phibro Animal Health Corporation | 53.31 Million USD | 116.529% |
| Procaps Group S.A. | 52.32 Million USD | 116.842% |
| TherapeuticsMD, Inc. | -8.52 Million USD | -3.394% |
| Regencell Bioscience Holdings Limited | -4.73 Million USD | -86.042% |
| Viatris Inc. | 766.2 Million USD | 101.15% |
| Sunshine Biopharma, Inc. | -4.78 Million USD | -84.153% |
| Rockwell Medical, Inc. | -6.67 Million USD | -32.118% |
| Incannex Healthcare Limited | -30.04 Million USD | 70.666% |
| Aytu BioPharma, Inc. | -5.25 Million USD | -67.725% |
| Tilray Brands, Inc. | -174.74 Million USD | 94.957% |
| Collegium Pharmaceutical, Inc. | 166.96 Million USD | 105.278% |
| PetIQ, Inc. | 60.01 Million USD | 114.683% |
| Silver Spike Investment Corp. | 7.34 Million USD | 220.057% |
| Neurocrine Biosciences, Inc. | 250.9 Million USD | 103.512% |
| Journey Medical Corporation | -2.07 Million USD | -325.098% |
| Alimera Sciences, Inc. | -1.47 Million USD | -499.067% |
| Petros Pharmaceuticals, Inc. | -13.61 Million USD | 35.286% |
| Assertio Holdings, Inc. | -243.53 Million USD | 96.382% |
| Shuttle Pharmaceuticals Holdings, Inc. | -5.89 Million USD | -49.554% |
| Embecta Corp. | 221.5 Million USD | 103.978% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 56.049% |
| Procaps Group, S.A. | 38.97 Million USD | 122.611% |
| PainReform Ltd. | -9.58 Million USD | 8.052% |
| Avadel Pharmaceuticals plc | -137.84 Million USD | 93.607% |
| Talphera, Inc. | -16.88 Million USD | 47.822% |
| Pacira BioSciences, Inc. | 87.67 Million USD | 110.051% |
| Alvotech | -354.86 Million USD | 97.517% |
| Lantheus Holdings, Inc. | 364.64 Million USD | 102.417% |
| Kamada Ltd. | 10.06 Million USD | 187.562% |
| Indivior PLC | -4 Million USD | -120.307% |
| Currenc Group, Inc. | -6.64 Million USD | -32.6% |
| Evoke Pharma, Inc. | -7.43 Million USD | -18.59% |
| Flora Growth Corp. | -50.35 Million USD | 82.499% |
| Cyclo Therapeutics, Inc. | -20.05 Million USD | 56.049% |
| Evolus, Inc. | -49.23 Million USD | 82.101% |
| HUTCHMED (China) Limited | 18.37 Million USD | 147.958% |
| Amphastar Pharmaceuticals, Inc. | 196.98 Million USD | 104.474% |
| Akanda Corp. | -10.05 Million USD | 12.328% |